Applied immunology : nature.com subject feedshttps://www.nature.com/subjects/applied-immunology.atom2024-03-28T15:56:02+00:00A novel multi-variate immunological approach, reveals immune variation associated with environmental conditions, and co-infection in the koala (Phascolarctos cinereus)https://www.nature.com/articles/s41598-024-57792-72024-03-27T00:00:00+00:002024-03-27T00:00:00+00:00Cristina M. Fernandez et al.Affinity maturation of CRISPR-engineered B cell receptors in vivohttps://www.nature.com/articles/s41551-024-01184-92024-03-20T00:00:00+00:002024-03-20T00:00:00+00:00Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virushttps://www.nature.com/articles/s41541-024-00855-72024-03-19T00:00:00+00:002024-03-19T00:00:00+00:00Shuai Shao et al.In vivo affinity maturation of mouse B cells reprogrammed to express human antibodieshttps://www.nature.com/articles/s41551-024-01179-62024-03-14T00:00:00+00:002024-03-14T00:00:00+00:00Yiming Yin et al.Strategies for targeting cytokines in inflammatory bowel diseasehttps://www.nature.com/articles/s41577-024-01008-62024-03-14T00:00:00+00:002024-03-14T00:00:00+00:00Markus F. NeurathDevelopment of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myelomahttps://www.nature.com/articles/s41467-024-46310-y2024-03-06T00:00:00+00:002024-03-06T00:00:00+00:00C. Grandclément et al.Author Correction: Differential peripheral immune signatures elicited by vegan versus ketogenic diets in humanshttps://www.nature.com/articles/s41591-024-02884-02024-02-27T00:00:00+00:002024-02-27T00:00:00+00:00Verena M. Link et al.Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicityhttps://www.nature.com/articles/s41541-024-00832-02024-02-24T00:00:00+00:002024-02-24T00:00:00+00:00Yueru Zhang et al.Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccineshttps://www.nature.com/articles/s41541-024-00835-x2024-02-23T00:00:00+00:002024-02-23T00:00:00+00:00Ki Hyun Bae et al.Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccinehttps://www.nature.com/articles/s41541-024-00830-22024-02-21T00:00:00+00:002024-02-21T00:00:00+00:00David G. Alleva et al.Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutininshttps://www.nature.com/articles/s41467-024-44889-w2024-02-12T00:00:00+00:002024-02-12T00:00:00+00:00Daniëla Maria Hinke et al.Efficacy evaluation of a bivalent subunit vaccine against classical swine fever virus and porcine circovirus type 2https://www.nature.com/articles/s41598-024-53624-w2024-02-06T00:00:00+00:002024-02-06T00:00:00+00:00Yu-San Chen et al.MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine productionhttps://www.nature.com/articles/s41467-024-45145-x2024-02-06T00:00:00+00:002024-02-06T00:00:00+00:00Cheng Gao et al.Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapyhttps://www.nature.com/articles/s41467-024-44941-92024-01-31T00:00:00+00:002024-01-31T00:00:00+00:00Mingming Zhao et al.Differential peripheral immune signatures elicited by vegan versus ketogenic diets in humanshttps://www.nature.com/articles/s41591-023-02761-22024-01-30T00:00:00+00:002024-01-30T00:00:00+00:00Verena M. Link et al.Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particleshttps://www.nature.com/articles/s41541-024-00808-02024-01-25T00:00:00+00:002024-01-25T00:00:00+00:00Filippo Carboni et al.Personalized mRNA vaccine boosts melanoma immunotherapyhttps://www.nature.com/articles/d41591-024-00006-42024-01-25T00:00:00+00:002024-01-25T00:00:00+00:00Karen O’LearyTweaks in vaccinehttps://www.nature.com/articles/s41589-024-01548-x2024-01-24T00:00:00+00:002024-01-24T00:00:00+00:00Yiyun SongMucosal boostinghttps://www.nature.com/articles/s41590-024-01751-x2024-01-23T00:00:00+00:002024-01-23T00:00:00+00:00Ioana StaicuNeutrophil-mediated type IV collagen degradation is elevated in patients with mild endoscopic ulcerative colitis reflecting early mucosal destructionhttps://www.nature.com/articles/s41598-024-52208-y2024-01-18T00:00:00+00:002024-01-18T00:00:00+00:00Marta S. Alexdottir et al.Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asperhttps://www.nature.com/articles/s41467-023-42624-52024-01-16T00:00:00+00:002024-01-16T00:00:00+00:00Christoffer V. Sørensen et al.Bringing immunofocusing into focushttps://www.nature.com/articles/s41541-023-00792-x2024-01-09T00:00:00+00:002024-01-09T00:00:00+00:00Sriharshita Musunuri et al.Immunophenotyping of hemocytes from infected Galleria mellonella larvae as an innovative tool for immune profiling, infection studies and drug screeninghttps://www.nature.com/articles/s41598-024-51316-z2024-01-08T00:00:00+00:002024-01-08T00:00:00+00:00Marialucia Gallorini et al.Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profilinghttps://www.nature.com/articles/s42003-023-05744-82024-01-08T00:00:00+00:002024-01-08T00:00:00+00:00Matthew I. J. Raybould et al.Absolute quantitation of binding antibodies from clinical sampleshttps://www.nature.com/articles/s41541-023-00793-w2024-01-06T00:00:00+00:002024-01-06T00:00:00+00:00Chan Tang et al.Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adultshttps://www.nature.com/articles/s41590-023-01717-52024-01-05T00:00:00+00:002024-01-05T00:00:00+00:00Sathyabaarathi Ravichandran et al.Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine designhttps://www.nature.com/articles/s41541-023-00798-52024-01-04T00:00:00+00:002024-01-04T00:00:00+00:00Emeline Vernhes et al.Immune imprintinghttps://www.nature.com/articles/s41590-023-01729-12024-01-02T00:00:00+00:002024-01-02T00:00:00+00:00Ioana VisanA candidate antibody drug for prevention of malariahttps://www.nature.com/articles/s41591-023-02659-z2024-01-02T00:00:00+00:002024-01-02T00:00:00+00:00Katherine L. Williams et al.Assessing the toxicity of bispecific antibodieshttps://www.nature.com/articles/s41551-023-01163-62023-12-22T00:00:00+00:002023-12-22T00:00:00+00:00Marta Buzzetti et al.